International standards describing extractables and leachables (E&L) testing for chemical analyses are not prescriptive allowing much scope for interpretation. Balancing the requirements of regulatory agencies with issues of laboratory-based practicality and feasibility is challenging in the E&L analysis of advanced wound dressings, specifically the expectation of testing under 'exhaustive' conditions in three solvents (polar, semi-polar, non-polar) when not all of the test conditions/solvents are compatible with common wound dressing materials (e.g. silicone adhesives, polyurethanes). The aim of this study is to describe a rigorous E&L testing framework, aligning with the clinical usage of wound dressings whilst remaining strongly aligned with regulatory standards. Five major practical challenges were identified relating to the selection of suitable E&L solvents, including: selection of extraction conditions, inappropriate swelling, loss of device integrity, formation of particulates, and choice of appropriate analytical techniques. A systematic process was developed to identify acceptable/compatible solvents and justify the omission of solvents shown to be incompatible. A test case was developed to demonstrate how the framework can be adopted in support of real-life regulatory submissions. This systematic approach to design of E&L analysis of wound dressings may be useful in streamlining future regulatory submissions for medical devices including advanced wound dressings.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: